1Mechanisms implicated in the contralateral effect in the central nervous system after unilateral injury: focus on the visual systemFernando Lucas-Ruiz, Caridad Galindo-Romero, Virginia Albaladejo-García, Manuel Vidal-Sanz, Marta Agudo-Barriuso2125-21312Toward three-dimensional in vitro models to study neurovascular unit functions in health and diseaseTara M.Caffrey, Emily B.Button, Jerome Robert2132-21403Apolipoprotein A1, the neglected relative of Apolipoprotein E and its potential role in Alzheimer's diseaseKristina Endres2141-21484Oral frailty and neurodegeneration in Alzheimer's diseaseVittorio Dibello, Madia Lozupone, Daniele Manfredini, Antonio Dibello, Roberta Zupo, Rodolfo Sardone, Antonio Daniele, Frank Lobbezoo, Francesco Panza2149-21535Non-coding RNAs and other determinants of neuroinflammation and endothelial dysfunction: regulation of gene expression in the acute phase of ischemic stroke and possible therapeutic applicationsMario Daidone, Marco Cataldi, Antonio Pinto, Antonino Tuttolomondo2154-21586Altered microRNA expression in animal models of Huntington's disease and potential therapeutic strategiesBridget Martinez, Philip V.Peplow2159-21697Mesenchymal stem cell treatment for peripheral nerve injury: a narrative reviewRui-Cheng Zhang, Wen-Qi Du, Jing-Yuan Zhang, Shao-Xia Yu, Fang-Zhi Lu, Hong-Mei Ding, Yan-Bo Cheng, Chao Ren, De-Qin Geng2170-21768Corneal neuromediator profiles following laser refractive surgeryLily Wei Yun Yang, Jodhbir S.Mehta, Yu-Chi Liu2177-21839Neuroimmune connections between corticotropin- releasing hormone and mast cells: novel strategies for the treatment of neurodegenerative diseasesPiplu Bhuiyan, Yi-Wei Wang, Huan-Huan Sha, Hong-Quan Dong, Yan-Ning Qian2184-219710Searching for alternatives to brain regenerationChiara La Rosa, Luca Bonfanti2198-220011Mitofusin activation enhances mitochondrial motility and promotes neuroregeneration in CMT2AGerald W.Dorn Ⅱ2201-220312Chitosan-based nanoparticles in Alzheimer's disease: messenger or message?Eniko Manek, Georg A.Petroianu2204-220513Neutrophil in diabetic stroke: emerging therapeutic strategiesRashmi Kumari, Kusum Sinha2206-220814Evaluation of glial cell proliferation with non-invasive molecular imaging methods after strokeAna Joya, Abraham Martín2209-221015It takes more than tau to tangle: using proteomics to determine how phosphorylated tau mediates toxicity in neurodegenerative diseasesGeoffrey Pires, Eleanor Drummond2211-221216A biophysical perspective on the unexplored mechanisms driving Parkinson's disease by amphetamine-like stimulantsCarla Ferreira, Joana Couceiro, Sandra Tenreiro, Alexandre Quintas2213-221417Glycans to improve efficacy and solubility of protein aggregation inhibitorsAshim Paul, Daniel Segal, Elsa Zacco2215-221618Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer's diseaseIda Manna, Selene De Benedittis, Enrico Iaccino, Andrea Quattrone, Aldo Quattrone2217-221819Alpha-synuclein preformed fibrils: a tool to understand Parkinson's disease and develop disease modifying therapyPiotr Chmielarz, Andrii Domanskyi2219-222120Exploring the contribution of the mitochondrial disulfide relay system to Parkinson's disease: the PINK1/CHCHD4 interplayGiuseppe Arena, Nazanine Modjtahedi, Rejko Kruger2222-2224 